Global Cord Blood Corporation
CO was delisted on the 23rd of September, 2022.
28 hedge funds and large institutions have $45.1M invested in Global Cord Blood Corporation in 2021 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 7 reducing their positions, and 7 closing their positions.
29% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 7
4% more call options, than puts
Call options by funds: $50K | Put options by funds: $48K
0.46% more ownership
Funds ownership: 8.4% → 8.86% (+0.46%)
0% more funds holding
Funds holding: 28 → 28 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
5% less capital invested
Capital invested by funds: $47.7M → $45.1M (-$2.55M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OMC
Oasis Management Company
Grand Cayman,
Cayman Islands
|
+$1.7M |
| 2 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.08M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$847K |
| 4 |
Rockefeller Capital Management
New York
|
+$336K |
| 5 |
MGIA
Moneta Group Investment Advisors
St Louis,
Missouri
|
+$42.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barclays
London,
United Kingdom
|
-$957K |
| 2 |
Renaissance Technologies
New York
|
-$753K |
| 3 |
Man Group
London,
United Kingdom
|
-$277K |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$205K |
| 5 |
Millennium Management
New York
|
-$102K |
CO Hedge Fund Activity: Q4 2021 in Review
28 of the 6,518 institutional investors tracked by Wall St. Rank reported a position in Global Cord Blood Corporation (CO) for Q4 2021, worth a combined $45.1M — down 5.3% from $47.7M a quarter earlier.
Fund positioning in CO was balanced in Q4 2021: 7 funds opened new positions, 7 closed out, 9 added to existing stakes and 7 trimmed.
The largest buyer was Oasis Management Company, adding an estimated $1.7M. The largest seller was Barclays, exiting entirely with an estimated $957K sold.
- 28 institutional investors held Global Cord Blood Corporation (CO) as of Q4 2021, unchanged from Q3 2021.
- Funds reported $45.1M of Global Cord Blood Corporation stock for Q4 2021, down 5.3% quarter-over-quarter.
- 7 funds opened new Global Cord Blood Corporation positions in Q4 2021 and 7 closed out, a net change of 0 holders.
- The largest Global Cord Blood Corporation buyer in Q4 2021 was Oasis Management Company, an estimated $1.7M added.
- The largest Global Cord Blood Corporation seller in Q4 2021 was Barclays, an estimated $957K sold.
Based on aggregated 13F filings for Q4 2021.